European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Improving monitoring and environmental risk assessment of pharmaceuticals, antimicrobial resistance and pathogens from terrestrial to aquatic environments

Descrizione del progetto

Proteggere il nostro pianeta dall’inquinamento farmaceutico

La contaminazione del suolo globale e degli ecosistemi acquatici a causa di farmaci, microrganismi resistenti agli antimicrobici e agenti patogeni è un problema che minaccia l’ambiente e il benessere umano, per il quale è necessario trovare urgentemente una soluzione. Con il sostegno del programma di azioni Marie Skłodowska-Curie, il progetto Pharm-ERA riunisce accademici, operatori pubblici e privati e responsabili politici dell’UE per affrontare questa pressante preoccupazione. Svolgendo 10 progetti di dottorato che abbracciano discipline scientifiche di svariato tipo, quali chimica ambientale, ecotossicologia, ecologia microbica, biologia molecolare e modellizzazione, Pharm-ERA si prefigge di sviluppare soluzioni innovative e di migliorare le tecniche di monitoraggio e la valutazione dei rischi ambientali. L’obiettivo finale del progetto è proteggere la diversità e le funzioni della vita microbica negli ecosistemi contaminati, garantendo la sostenibilità del nostro pianeta e promuovendo al contempo la salute umana e animale.

Obiettivo

Global contamination of soil and aquatic ecosystems by pharmaceutical and microbiological pollutants (such as antimicrobial-resistant microorganisms and/or pathogens) raises severe concerns about impacts on ecosystem health and repercussions on humans and animals. Preserving ecosystems from adverse ecotoxicological effects of pharmaceuticals and their transformation products and limiting the environmental spread of antimicrobial resistance and pathogens is imperative to reach several UN Sustainable Development Goals as well as the European Green Deal, Water Framework Directive and Biodiversity Strategy for 2030. To meet these huge environmental and societal challenges, public and private stakeholders and EU policy makers require improved monitoring and Environmental Risk Assessment to protect microbial diversity and functions in contaminated ecosystems.
Pharm-ERA proposes a high-level interdisciplinary and intersectoral research and training network based on 10 doctoral projects covering scientific disciplines including environmental and analytical chemistry, microbial ecology, ecotoxicology, molecular biology (incl. multi-omics approaches) and chemical fate/effect modelling. Pharm-ERA involves 9 Beneficiaries (including 2 non-academics) and 6 Associated Partners (including 5 non-academics), committed to contribute to research, training, dissemination, communication and exploitation of results targeting end-users such as Environmental consultancies and agencies.
Pharm-ERA will provide EU with high-level scientific experts who will further shape and implement the next generation of environmental management strategies, EU guidelines and regulations to reduce the adverse environmental effects and risks of pharmaceuticals and the spread of antimicrobial resistance and pathogens in terrestrial and aquatic environments. This will ensure sustainability of our ecosystems, fostering positive impacts on human and animal health and well-being far beyond the Pharm-ERA project

Coordinatore

INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
Contribution nette de l'UE
€ 565 387,20
Indirizzo
147 RUE DE L'UNIVERSITE
75007 Paris
Francia

Mostra sulla mappa

Regione
Ile-de-France Ile-de-France Paris
Tipo di attività
Research Organisations
Collegamenti
Costo totale
Nessun dato

Partecipanti (7)

Partner (12)